Fig. 2.

Cyclin G2 inhibits the proliferation and migration of SGC-7901 or MGC-803 gastric cancer cells. a Western blot analysis for the cyclin G2 protein levels in cyclin G2 overexpression and knockdown SGC-7901 or MGC-803 cells. b MTS cell proliferation assay in cyclin G2 overexpression and cyclin G2 knockdown SGC-7901 or MGC-803 cells (n = 3).*P < 0.05; **P < 0.01. c and d Colony formation assay in cyclin G2 overexpression and cyclin G2 knockdown SGC-7901 or MGC-803 cells (n = 3).*P < 0.05; **P < 0.01. e and f Representative images and quantification of cell cycle analysis after cyclin G2 overexpression in SGC-7901 cells by flow cytometry. g and h Representative images and quantification of the wound healing assay in cyclin G2 overexpression and cyclin G2 knockdown SGC-7901 or MGC-803 cells (n = 3).*P < 0.05; **P < 0.01. i and j Representative Transwell® migration assays in cyclin G2 overexpression SGC-7901 or MGC-803 cells determined by stained with Giemsa. The migration ratio is expressed as a percentage of the control cells at the indicated time-points (n = 3). **P < 0.01